BioNTech SE (BNTX)

NASDAQHealthcare

$91.38
+$1.95 (+2.2%)
Market closed

April 2, 2026 at 20:00 UTC

Interactive Chart

BNTX
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

16:50:03 UTC

About BioNTech SE

Name
BioNTech SE
CEO
Ugur Sahin
Industry
Healthcare
Year Founded
2008
Employees
6,772

BioNTech SE is a biotechnology company that turns insights in immunology into therapies designed for serious diseases. The model links research platforms with clinical programs and manufacturing methods that can be scaled when evidence supports them. Work spans mRNA and other modalities, but the operating tone stays consistent: design carefully, test with rigor, and communicate results so physicians and regulators can act with confidence. Partnerships extend reach without changing that core rhythm. The goal is to move promising ideas into treatments that fit the routines of modern medicine, with supply and guidance that are as clear as the science behind them.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 6 Buy, 9 Hold, 8 Sell
Buy6
Hold9
Sell8

Fundamentals & Financials

Revenue (TTM)
$2.8B
Net Income (TTM)
-$1.1B
EPS (TTM)
-$4.68
ROA (TTM)
-5.15%
Current Ratio
7.54
Dividend Yield
0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue$898,890.9K
Cost of Sales$330,174.5K
Gross Profit$568,716.4K
Operating Income-$230,616.9K
Net Income-$302,139.9K
EPS-$1.23

Technical Indicators

BioNTech SE's Technical Indicators Summary

BNTX presents a neutral technical picture with short-term averages near the current price while medium- and long-term averages remain above, leaving the stock between timeframes. Momentum indicators are mixed and largely neutral, and ADX points to no strong directional trend. Volatility is moderate and on-balance volume has been negative, which tempers the modest short-term bullish bias from the nearest moving averages. The pivot sits just under the market but is not decisive. Technical takeaway: Neutral — mixed momentum and subdued trend strength keep bias balanced.

Buy
6 signals
Neutral
9 signals
Sell
8 signals
Overall: Neutral39% Neutral signals
IndicatorValue
RSI (14)
45.86
Stochastic %K (14, 3, 3)
48.71
CCI (20)
-1.08
WPR (14)
-38.22
Momentum (10)
1.87
MFI
46.00
MACD Level (12, 26)
-3.72
Bollinger Bands
$81.01 - $99.54
ATR (14)
$3.58 (3.92%)
ADX (14)
23.69
OBV
-13,729,500
Classic Pivot Point
$89.64
Fibonacci Pivot Point
$89.64
Simple Moving Averages
$88.11 - $103.44(5 indicators)
Exponential Moving Averages
$89.16 - $102.15(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the end of trading, BNTX held a small 1.97% gain from yesterday's close, settling at 91.18. Into the bell, a small sector dip of -0.62% left a soft macro backdrop for BNTX. BNTX edged higher as a modest sector dip and soft macro backdrop limited gains.

Price Change

from $91.38 close

-$0.1

Trading Volume

Below avg (874.0K)

776.5K

vs S&P 500 Today

Outperforming Market

+1.65%

52-Week Position

Lower range

26.2%

Updated: April 3, 2026 at 20:10 UTC

Quote Summary

OpenPrevious Close
$87.67$91.38
Day Range52 Week Range
$87.45 - $91.43$79.52 - $124
VolumeAvg. Volume
776.5K1.1M
Market CapP/E Ratio
$22.9B-20.8